These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 3155882

  • 1. Ly-1+2- suppressor T cells inhibit the expression of passively transferred antitumor immunity by suppressing the generation of cytolytic T cells.
    Mills CD, North RJ.
    Transplantation; 1985 Feb; 39(2):202-8. PubMed ID: 3155882
    [Abstract] [Full Text] [Related]

  • 2. Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells.
    Mills CD, North RJ.
    J Exp Med; 1983 May 01; 157(5):1448-60. PubMed ID: 6189937
    [Abstract] [Full Text] [Related]

  • 3. Ly 1+2- suppressor T cells down-regulate the generation of Ly 1-2+ effector T cells during progressive growth of the P815 mastocytoma.
    North RJ, Dye ES.
    Immunology; 1985 Jan 01; 54(1):47-56. PubMed ID: 3156088
    [Abstract] [Full Text] [Related]

  • 4. T cell suppressors of antitumor immunity. The production of Ly-1-,2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity.
    DiGiacomo A, North RJ.
    J Exp Med; 1986 Oct 01; 164(4):1179-92. PubMed ID: 2944983
    [Abstract] [Full Text] [Related]

  • 5. Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.
    North RJ, Bursuker I.
    J Exp Med; 1984 May 01; 159(5):1295-311. PubMed ID: 6232335
    [Abstract] [Full Text] [Related]

  • 6. The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells.
    Dye ES.
    J Immunol; 1986 Feb 15; 136(4):1510-5. PubMed ID: 3080526
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Specificity of the T cells that mediate and suppress adoptive immunotherapy of established tumors.
    Dye ES, North RJ.
    J Leukoc Biol; 1984 Jul 15; 36(1):27-37. PubMed ID: 6234371
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The therapeutic significance of concomitant antitumor immunity. II. Passive transfer of concomitant immunity with Ly-1+2- T cells primes established tumors in T cell-deficient recipients for endotoxin-induced regression.
    North RJ.
    Cancer Immunol Immunother; 1984 Jul 15; 18(2):75-9. PubMed ID: 6391656
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Two distinct mechanisms regulate the in vivo generation of cytotoxic T cells.
    Sy MS, Lee SH, Tsurufuji M, Rock KL, Benacerraf B, Finberg R.
    J Exp Med; 1982 Sep 01; 156(3):918-23. PubMed ID: 6213734
    [Abstract] [Full Text] [Related]

  • 13. The immune response of the mouse to lymphocytic choriomeningitis virus. V. High numbers of cytolytic T lymphocytes are generated in the spleen during acute infection.
    Moskophidis D, Assmann-Wischer U, Simon MM, Lehmann-Grube F.
    Eur J Immunol; 1987 Jul 01; 17(7):937-42. PubMed ID: 2886344
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunoregulatory circuits which modulate responsiveness to suppressor cell signals: characterization of an effector cell in the contrasuppressor circuit.
    Green DR, Eardley DD, Kimura A, Murphy DB, Yamauchi K, Gershon RK.
    Eur J Immunol; 1981 Dec 01; 11(12):973-80. PubMed ID: 6459945
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S, Yamamoto H, Fujii Y, Arai S.
    Cancer Res; 1986 Nov 01; 46(11):5548-52. PubMed ID: 2428480
    [Abstract] [Full Text] [Related]

  • 19. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H, Fukuzawa M, Yoshioka T, Nakajima H, Hamaoka T.
    J Immunol; 1984 Sep 01; 133(3):1671-6. PubMed ID: 6205091
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of suppression in the transfer of contact sensitivity. Analysis of an I-J+ molecule required for Ly2 suppressor cell activity.
    Ptak W, Gershon RK, Flood PM.
    J Exp Med; 1983 Dec 01; 158(6):1822-35. PubMed ID: 6196432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.